Dosage: One tablet daily or as directed by a physician or pharmacist
Diab Vasc Dis Res 14:295303 Nystrom T, Bodegard J, Nathanson D et al (2017) Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemia
[1] [2] Patients may legitimately require both medications simultaneouslyfor example, someone with obesity and rheumatoid arthritis, or a patient with asthma requiring corticosteroid therapy who is also managing weight-related health conditions
You can access the study here: NEJM Semaglutide for Weight Loss
It is a complex interplay of hormones, brain signaling, and metabolic function that we can now target with incredible precision, backed by science
Speaker Andrew Peseski, DO (Assistant Professor of Medicine, Division of Hematology, Duke University Medical Center) This weekly conference is held each Tuesday from 8-9 a.m